Clinical Performance Partners, Inc. (CPP) announces the launch of their website (www.clinicalperformancepartners.com).
Contact: Beth Harper FOR IMMEDIATE RELEASE
Phone: 817-946-4892
Email: bharper@clinicalperformancepartners.com
CLINICAL PERFORMANCE PARTNERS LAUNCHES NEW WEBSITE
KELLER, TX June 19, 2008 – Clinical Performance Partners, Inc. (CPP) announces the launch of their website (www.clinicalperformancepartners.com).
“In addition to establishing a web presence for the company, the goal of the website is to serve as a valuable resource to the industry for all things related to patient recruitment / retention and site relationship management” says Beth Harper, President of Clinical Performance Partners, Inc.
The website features a listing of patient recruitment service providers with links to their websites. In addition, viewers can search for articles related to patient recruitment and site relationship management, as well as download sample tools and templates developed by CPP, Inc.
“As a long-time champion and advocate for educating the industry on the process and practice of patient recruitment, I am delighted to share my interest, experience and resources as we all strive to overcome the chronic challenges associated with patient recruitment” says Harper.
“Predicting, managing, supporting and enhancing site performance in clinical trials is not only our mission by my personal passion” notes Harper who celebrates some 25 years of “in the trenches” healthcare and clinical research experience this year.
About Clinical Performance Partners - CPP is a consulting firm dedicated to designing and implementing innovative and practical solutions for improving site performance and accelerating clinical trials results for the Life Sciences Industry. www.clinicalperformancepartners.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.